21Indexed trials
mesh condition
Hypertension
Intelligence
Hypertension intelligence: 21 indexed trials, 5 recruiting studies, 21 sponsors across 15 countries.
5Recruiting
21Sponsors
15Countries
Leading sponsors
Cairo University10 recruiting
China National Center for Cardiovascular Diseases11 recruiting
GlaxoSmithKline10 recruiting
International Rescue Committee10 recruiting
Istituto Clinico Humanitas10 recruiting
Johns Hopkins University10 recruiting
King's College London10 recruiting
Marymount University11 recruiting
Mayo Clinic10 recruiting
NYU Langone Health10 recruiting
National Taipei University of Nursing and Health Sciences10 recruiting
Novartis Pharmaceuticals11 recruiting
Geographic activity
United States9trials
China2trials
Egypt1trials
Indonesia1trials
Israel1trials
Italy1trials
Australia1trials
Netherlands1trials
Singapore1trials
Spain1trials
Taiwan1trials
Thailand1trials
Leading interventions
Angiotensin II Receptor Blockers (ARBs, losartan) and Calcium Channel Blockers (CCB, amlodipine)1trials
Approach A (PeeSpot urine collection device).1trials
Approach B (ACR | EU Test kit).1trials
Cardiovascular Assessments1trials
Carotid Stenting (CAS)1trials
Carotid endarterectomy (CEA)1trials
Clevidipine1trials
Common Elements Treatment Approach1trials
Emotional/ Behavioural assessments1trials
Foot Mechanical Stimulation (Gondola®, CE marking n° 0476)1trials
GP only1trials
Actigraphy1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.